MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Knight TherapeuticsInc-License Agreement...$22K License AgreementDevelopment...$1K Knight TherapeuticsInc-License Agreement...$5,534K Kyowa KirinCo.Ltd-License Agreement...$3,906K Product XPHOZAH$49,052K Product IBSRELA$65,350K Comprehensive loss-$333K Unrealized gains (losses)on...$74K Non Cash RoyaltyRelated To Sale Of Future...$1,350K License$23K Product Supply Revenue$9,440K Product$114,402K Net loss-$407K Total revenues$125,215K something is missing$28,688K Provision for income taxes$7K Loss beforeprovision for income taxes-$400K Other income, net$2,078K Loss from operations$5,099K Total costs andoperating expenses$148,804K Non-cash interestexpense related to the...$1,818K Interest expense$5,759K Selling, general andadministrative$86,411K Research and development$22,856K Cost of sales$10,849K something is missing$28,688K
Income Statement
source: myfinsight.com

ARDELYX, INC. (ARDX)

ARDELYX, INC. (ARDX)